STANDARD BIOTOOLS INC. Operating Income Loss

• STANDARD BIOTOOLS INC. showed an increase of +13.5% in Operating Income Loss from 2024 to 2025.
• This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: -$4.23 million | Q3 2010: -$3.10 million | Q1 2011: -$4.88 million | Q2 2011: -$6.65 million | Q3 2011: -$4.06 million | Q1 2012: -$6.28 million | Q2 2012: -$4.39 million | Q3 2012: -$3.91 million | Q1 2013: -$5.07 million | Q2 2013: -$3.99 million | Q3 2013: -$4.95 million | Q1 2014: -$16.58 million | Q2 2014: -$12.38 million | Q3 2014: -$13.05 million | Q1 2015: -$14.00 million | Q2 2015: -$14.66 million | Q3 2015: -$7.80 million | Q1 2016: -$18.87 million | Q2 2016: -$18.14 million | Q3 2016: -$18.48 million | Q1 2017: -$17.54 million | Q2 2017: -$16.49 million | Q3 2017: -$15.60 million | Q1 2018: -$12.63 million | Q2 2018: -$12.79 million | Q3 2018: -$11.63 million | Q1 2019: -$14.21 million | Q2 2019: -$14.64 million | Q3 2019: -$13.82 million | Q1 2020: -$14.94 million | Q2 2020: -$13.73 million | Q3 2020: -$5.46 million | Q1 2021: -$19.32 million | Q2 2021: -$17.27 million | Q3 2021: -$19.61 million | Q1 2022: -$27.50 million | Q2 2022: -$38.56 million | Q3 2022: -$29.03 million | Q1 2023: -$16.59 million | Q2 2023: -$17.45 million | Q3 2023: -$21.17 million | Q1 2024: -$60.18 million | Q2 2024: -$30.26 million | Q3 2024: -$26.70 million | Q1 2025: -$32.97 million | Q2 2025: -$25.70 million | Q3 2025: -$32.94 million.
• Over the full 17 years of available data (2009 to 2025), STANDARD BIOTOOLS INC.'s Operating Income Loss has declined by 511.2%.
• Historical annual values: Fiscal year 2025: -$110.25 million | Fiscal year 2024: -$127.49 million | Fiscal year 2023: -$76.60 million | Fiscal year 2022: -$116.21 million | Fiscal year 2021: -$67.46 million | Fiscal year 2020: -$51.04 million | Fiscal year 2019: -$51.84 million | Fiscal year 2018: -$48.16 million | Fiscal year 2017: -$58.36 million | Fiscal year 2016: -$73.19 million | Fiscal year 2015: -$50.16 million | Fiscal year 2014: -$51.84 million | Fiscal year 2013: -$18.65 million | Fiscal year 2012: -$18.07 million | Fiscal year 2011: -$18.57 million | Fiscal year 2010: -$14.57 million | Fiscal year 2009: -$18.04 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026